1445 related articles for article (PubMed ID: 16322242)
1. Prospective identification of tumorigenic prostate cancer stem cells.
Collins AT; Berry PA; Hyde C; Stower MJ; Maitland NJ
Cancer Res; 2005 Dec; 65(23):10946-51. PubMed ID: 16322242
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
3. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
Heer R; Robson CN; Shenton BK; Leung HY
J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.
Gu G; Yuan J; Wills M; Kasper S
Cancer Res; 2007 May; 67(10):4807-15. PubMed ID: 17510410
[TBL] [Abstract][Full Text] [Related]
5. Identification of a cancer stem cell in human brain tumors.
Singh SK; Clarke ID; Terasaki M; Bonn VE; Hawkins C; Squire J; Dirks PB
Cancer Res; 2003 Sep; 63(18):5821-8. PubMed ID: 14522905
[TBL] [Abstract][Full Text] [Related]
6. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
Wei C; Guomin W; Yujun L; Ruizhe Q
Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
[TBL] [Abstract][Full Text] [Related]
8. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
[TBL] [Abstract][Full Text] [Related]
9. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system.
Fan X; Liu S; Su F; Pan Q; Lin T
Urol Oncol; 2012; 30(3):314-8. PubMed ID: 20843707
[TBL] [Abstract][Full Text] [Related]
10. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
[TBL] [Abstract][Full Text] [Related]
11. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells.
Rentala S; Chintala R; Guda M; Chintala M; Komarraju AL; Mangamoori LN
Biochem Biophys Res Commun; 2013 Nov; 441(3):586-92. PubMed ID: 24177008
[TBL] [Abstract][Full Text] [Related]
13. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
[TBL] [Abstract][Full Text] [Related]
14. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
[TBL] [Abstract][Full Text] [Related]
15. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
16. Novel human prostate epithelial cell culture models for the study of carcinogenesis and of normal stem cells and cancer stem cells.
Rhim JS; Li H; Furusato B
Adv Exp Med Biol; 2011; 720():71-80. PubMed ID: 21901619
[TBL] [Abstract][Full Text] [Related]
17. Identification and expansion of the tumorigenic lung cancer stem cell population.
Eramo A; Lotti F; Sette G; Pilozzi E; Biffoni M; Di Virgilio A; Conticello C; Ruco L; Peschle C; De Maria R
Cell Death Differ; 2008 Mar; 15(3):504-14. PubMed ID: 18049477
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C
Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
Aldahish A; Kale A; Aljameeli A; Shah GV
Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
[TBL] [Abstract][Full Text] [Related]
20. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP
Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]